ClinicalTrials.gov
public full text
Public Domain
Zavegepant Intranasal Spray for the Acute Treatment of Episodic Cluster Headache
The purpose of this study is to assess headache response rate for minimal pain at 30 minutes following zavegepant administration and to assess additional effectiveness and treatment failure endpoints at various timepoints after zavegepant administration
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- A Study to Learn About Zavegepant as the Acute Treatment of Migraine in Asian Adults#1007964
- Acute Treatment Trial in Adult Subjects With Migraines#1113842
- Treatment Response to GON Pulsed Radiofrequency in Elderly Patients With Chronic Migraine#808105
- Evaluation of Pharmacokinetics Profiles and Bactericidal Activity of Zabofloxacin#1087994
- Ascending Single Doses of Erenumab (AMG 334) in Healthy Adults and Migraine Patients#1072786
Record · ID 1230278
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive